| Dr Ryan Anthony Lani, MD | |
|
1400 Pennsylvania Ave, Tyrone, PA 16686-1728 | |
| (814) 684-2100 | |
| Not Available |
| Full Name | Dr Ryan Anthony Lani |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 1400 Pennsylvania Ave, Tyrone, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740716695 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD470341 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Home Healthcare Of Central Pennsylvania | Altoona, PA | Home health agency |
| Omni Home Care | Tyrone, PA | Home health agency |
| Upmc Altoona | Altoona, PA | Hospital |
| Tyrone Regional Health Network | Tyrone, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upmc Altoona Regional Health Services, Inc. | 5395659312 | 214 |
News Archive
Talecris Biotherapeutics, Inc., today announced results of a new survey showing that Gamunex® (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) is the preferred immune globulin intravenous (IGIV) among neurologists who indicated a brand preference. In the survey, conducted online by Harris Interactive® on behalf of Talecris, neurologists selected Gamunex over four times more often than all other available liquid IGIV therapies, with a statistically significant margin (p<0.05).
LDR, a privately held company with innovative spinal implants for both non-fusion and fusion applications, reached the critical 24-month follow-up phase for the one-level IDE study on its second generation Mobi-C® cervical artificial disc. LDR is the first and currently the only company to have completed enrollment for a concurrent one-level and two-level cervical artificial disc replacement study. LDR completed 1-Level enrollment in October 2007 and 2-Level enrollment in March 2008.
Sudden cardiac death is the leading cause of death in high school-aged athletes. To determine if SCD can be prevented with a heart screening, The Christ Hospital Health Network (Cincinnati, Ohio), The University of Mississippi Medical Center and Cincinnati Children's Hospital Medical Center partnered with USRowing and Toshiba America Medical Systems, Inc. to conduct The Athlete Heart Research Study.
Elsevier today announces that it has significantly increased its service offering to pharmaceutical R&D professionals with the launch of a new Pharmacokinetics Module of PharmaPendium-, the online resource for authoritative drug development data.
According to a new report released yesterday (15th June 2017) by the US Centers for Disease Control and Prevention (CDC) the number of teenagers who use e-cigarettes and other tobacco products is on the decline for the first time in years.
› Verified 8 days ago
| Entity Name | Upmc Altoona Regional Health Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396724217 PECOS PAC ID: 5395659312 Enrollment ID: O20040312000257 |
News Archive
Talecris Biotherapeutics, Inc., today announced results of a new survey showing that Gamunex® (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) is the preferred immune globulin intravenous (IGIV) among neurologists who indicated a brand preference. In the survey, conducted online by Harris Interactive® on behalf of Talecris, neurologists selected Gamunex over four times more often than all other available liquid IGIV therapies, with a statistically significant margin (p<0.05).
LDR, a privately held company with innovative spinal implants for both non-fusion and fusion applications, reached the critical 24-month follow-up phase for the one-level IDE study on its second generation Mobi-C® cervical artificial disc. LDR is the first and currently the only company to have completed enrollment for a concurrent one-level and two-level cervical artificial disc replacement study. LDR completed 1-Level enrollment in October 2007 and 2-Level enrollment in March 2008.
Sudden cardiac death is the leading cause of death in high school-aged athletes. To determine if SCD can be prevented with a heart screening, The Christ Hospital Health Network (Cincinnati, Ohio), The University of Mississippi Medical Center and Cincinnati Children's Hospital Medical Center partnered with USRowing and Toshiba America Medical Systems, Inc. to conduct The Athlete Heart Research Study.
Elsevier today announces that it has significantly increased its service offering to pharmaceutical R&D professionals with the launch of a new Pharmacokinetics Module of PharmaPendium-, the online resource for authoritative drug development data.
According to a new report released yesterday (15th June 2017) by the US Centers for Disease Control and Prevention (CDC) the number of teenagers who use e-cigarettes and other tobacco products is on the decline for the first time in years.
› Verified 8 days ago
| Entity Name | Upmc Altoona |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437100765 PECOS PAC ID: 8426962465 Enrollment ID: O20040406001118 |
News Archive
Talecris Biotherapeutics, Inc., today announced results of a new survey showing that Gamunex® (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) is the preferred immune globulin intravenous (IGIV) among neurologists who indicated a brand preference. In the survey, conducted online by Harris Interactive® on behalf of Talecris, neurologists selected Gamunex over four times more often than all other available liquid IGIV therapies, with a statistically significant margin (p<0.05).
LDR, a privately held company with innovative spinal implants for both non-fusion and fusion applications, reached the critical 24-month follow-up phase for the one-level IDE study on its second generation Mobi-C® cervical artificial disc. LDR is the first and currently the only company to have completed enrollment for a concurrent one-level and two-level cervical artificial disc replacement study. LDR completed 1-Level enrollment in October 2007 and 2-Level enrollment in March 2008.
Sudden cardiac death is the leading cause of death in high school-aged athletes. To determine if SCD can be prevented with a heart screening, The Christ Hospital Health Network (Cincinnati, Ohio), The University of Mississippi Medical Center and Cincinnati Children's Hospital Medical Center partnered with USRowing and Toshiba America Medical Systems, Inc. to conduct The Athlete Heart Research Study.
Elsevier today announces that it has significantly increased its service offering to pharmaceutical R&D professionals with the launch of a new Pharmacokinetics Module of PharmaPendium-, the online resource for authoritative drug development data.
According to a new report released yesterday (15th June 2017) by the US Centers for Disease Control and Prevention (CDC) the number of teenagers who use e-cigarettes and other tobacco products is on the decline for the first time in years.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ryan Anthony Lani, MD 1400 Pennsylvania Ave, Tyrone, PA 16686-1728 Ph: (814) 684-2100 | Dr Ryan Anthony Lani, MD 1400 Pennsylvania Ave, Tyrone, PA 16686-1728 Ph: (814) 684-2100 |
News Archive
Talecris Biotherapeutics, Inc., today announced results of a new survey showing that Gamunex® (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) is the preferred immune globulin intravenous (IGIV) among neurologists who indicated a brand preference. In the survey, conducted online by Harris Interactive® on behalf of Talecris, neurologists selected Gamunex over four times more often than all other available liquid IGIV therapies, with a statistically significant margin (p<0.05).
LDR, a privately held company with innovative spinal implants for both non-fusion and fusion applications, reached the critical 24-month follow-up phase for the one-level IDE study on its second generation Mobi-C® cervical artificial disc. LDR is the first and currently the only company to have completed enrollment for a concurrent one-level and two-level cervical artificial disc replacement study. LDR completed 1-Level enrollment in October 2007 and 2-Level enrollment in March 2008.
Sudden cardiac death is the leading cause of death in high school-aged athletes. To determine if SCD can be prevented with a heart screening, The Christ Hospital Health Network (Cincinnati, Ohio), The University of Mississippi Medical Center and Cincinnati Children's Hospital Medical Center partnered with USRowing and Toshiba America Medical Systems, Inc. to conduct The Athlete Heart Research Study.
Elsevier today announces that it has significantly increased its service offering to pharmaceutical R&D professionals with the launch of a new Pharmacokinetics Module of PharmaPendium-, the online resource for authoritative drug development data.
According to a new report released yesterday (15th June 2017) by the US Centers for Disease Control and Prevention (CDC) the number of teenagers who use e-cigarettes and other tobacco products is on the decline for the first time in years.
› Verified 8 days ago
Michael R Halter, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 Hospital Dr, Tyrone, PA 16686 Phone: 814-684-3101 Fax: 814-684-5539 | |
Ronald W Gregory, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 Penna Ave, Tyrone, PA 16686 Phone: 814-684-2100 Fax: 814-684-5828 | |
Dhurba Prasad Dhungana, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 154 Hospital Dr Ste 4, Tyrone, PA 16686 Phone: 814-684-1255 | |
Jason Henninger, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 863 S Lincoln Ave, Bellwood Office, Tyrone, PA 16686 Phone: 814-684-1245 |